Drug Interactions Database

6278 interactions from BNF 85 - Check your medicines

Source: BNF 85

Severity: All 6278 Severe 944 Moderate 1418 Unknown 3916

bupropion darifenacin

increases exposure

Unknown Study

bupropion digoxin

decreases exposure

Unknown Study

bupropion fenfluramine

increases exposure

Unknown Study

bupropion gefitinib

increases exposure

Unknown Theoretical

bupropion linezolid

increases risk of intraoperativehypertension

Unknown Anecdotal

bupropion metoprolol

increases exposure

Unknown Study

bupropion mexiletine

increases exposure

Unknown Study

bupropion nebivolol

increases exposure

Unknown Study

bupropion opioids

decreases efficacy

Unknown Theoretical

bupropion tamoxifen

decreases efficacy

Unknown Study

bupropion theactivemetaboliteoftetrabenazine

increases exposure

Unknown Study

bupropion tramadol

decreases efficacy

Unknown Study

cabazitaxel angiotensin-

affects exposure

Unknown Theoretical

cabazitaxel antihistamines,non-sedating

affects exposure

Unknown Theoretical

cabazitaxel atorvastatin

affects exposure

Unknown Theoretical

cabazitaxel fexofenadine

affects exposure

Unknown Theoretical

cabazitaxel glibenclamide

affects exposure

Unknown Theoretical

cabazitaxel meglitinides

affects exposure

Unknown Theoretical

cabazitaxel pravastatin

affects exposure

Unknown Theoretical

cabazitaxel repaglinide

affects exposure

Unknown Theoretical

cabazitaxel rosuvastatin

affects exposure

Unknown Theoretical

cabazitaxel simvastatin

affects exposure

Unknown Theoretical

cabazitaxel statins

affects exposure

Unknown Theoretical

cabazitaxel sulfonylureas

affects exposure

Unknown Theoretical

cabozantinib benzodiazepines

increases exposure

Unknown Theoretical

cabozantinib combinedhormonalcontraceptives

affects effects

Unknown Theoretical

cabozantinib midazolam

increases exposure

Unknown Theoretical

caffeinecitrate adenosine

decreases efficacy

Unknown Study

caffeinecitrate antiarrhythmics

decreases efficacy

Unknown Study

calciumchannelblockers afatinib

increases exposure

Unknown Study

calciumchannelblockers apixaban

increases exposure

Unknown Theoretical

calciumchannelblockers berotralstat

increases exposure

Unknown Study

calciumchannelblockers betablockers,non-selective

increases risk of cardiodepression

Unknown Study

calciumchannelblockers betablockers,selective

increases risk of cardiodepression

Unknown Study

calciumchannelblockers darifenacin

increases exposure

Unknown Study

calciumchannelblockers gilteritinib

increases exposure

Unknown Theoretical

calciumchannelblockers larotrectinib

increases exposure

Unknown Theoretical

calciumchannelblockers nintedanib

increases exposure

Unknown Study

calciumchannelblockers pibrentasvir

increases exposure

Unknown Theoretical

calciumchannelblockers relugolix

increases exposure

Unknown Study

calciumchannelblockers topotecan

increases exposure

Unknown Study

calciumchannelblockers trametinib

increases concentration

Unknown Theoretical

calciumchannelblockersarepredictedto increasetheexposuretoneurokinin-1receptorantagonists d andneurokinin-1receptorantagonists calciumchannelblockers

increases exposure

Unknown Study

calciumchannelblockersarepredictedto increasetheexposuretoneurokinin-1receptorantagonists d andneurokinin-1receptorantagonists diltiazem

increases exposure

Unknown Study

calciumchannelblockersarepredictedto increasetheexposuretoneurokinin-1receptorantagonists d andneurokinin-1receptorantagonists verapamil

increases exposure

Unknown Study

calciumchannelblockersincreasetheconcentration ofcarbamazepineandcarbamazepine verapamil

decreases exposure

Unknown Anecdotal

cannabidiol antiepileptics

increases risk of increasedaltconcentrations

Unknown Study

capecitabine antiepileptics

increases concentration

Unknown Anecdotal

capecitabine fosphenytoin

increases concentration

Unknown Anecdotal

capecitabine phenytoin

increases concentration

Unknown Anecdotal

Prev 1 ... 56 57 58 59 60 ... 126 Next

6278 interactions

Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.